These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 2147802

  • 1. [Plasmapheresis in the therapy of drug-induced toxicoderma].
    Davatdarova MM.
    Vestn Dermatol Venerol; 1990; (7):32-4. PubMed ID: 2147802
    [Abstract] [Full Text] [Related]

  • 2. Drug-induced skin eruptions: typical treatments for topical problems.
    Fisher AA.
    Geriatrics; 1979 Mar; 34(3):45-51. PubMed ID: 155021
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Drug eruptions in geriatric patients.
    Fisher AA.
    Cutis; 1976 Sep; 18(3):402-9. PubMed ID: 138570
    [No Abstract] [Full Text] [Related]

  • 5. Intravenous immunoglobulins and plasmapheresis combined treatment in patients with severe toxic epidermal necrolysis: preliminary report.
    Lissia M, Figus A, Rubino C.
    Br J Plast Surg; 2005 Jun; 58(4):504-10. PubMed ID: 15897036
    [Abstract] [Full Text] [Related]

  • 6. Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine.
    Friedmann PS, Strickland I, Pirmohamed M, Park BK.
    Arch Dermatol; 1994 May; 130(5):598-604. PubMed ID: 8179341
    [Abstract] [Full Text] [Related]

  • 7. [Plasmapheresis in dermatology].
    Potekaev NS, Kurdina MI, Orlov SL, Vorob'ev PA, Gorshkova NN, Barinov VG, Stareev VE.
    Ter Arkh; 1991 May; 63(10):133-8. PubMed ID: 1805412
    [Abstract] [Full Text] [Related]

  • 8. Plasmapheresis in severe drug-induced toxic epidermal necrolysis.
    Kamanabroo D, Schmitz-Landgraf W, Czarnetzki BM.
    Arch Dermatol; 1985 Dec; 121(12):1548-9. PubMed ID: 4062337
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Status of plasmapheresis for the treatment of toxic epidermal necrolysis in Japan.
    Yamada H, Takamori K.
    Ther Apher Dial; 2008 Oct; 12(5):355-9. PubMed ID: 18937717
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Drug-induced skin changes].
    Ratka P, Włoch J.
    Przegl Dermatol; 1980 Oct; 67(2):199-203. PubMed ID: 6447319
    [No Abstract] [Full Text] [Related]

  • 14. [The current concepts of acute toxic-allergic drug reactions and their treatment aspects].
    Latysheva TV, Gushchin IS, Poroshina IuA.
    Ter Arkh; 1991 Oct; 63(10):25-37. PubMed ID: 1839582
    [No Abstract] [Full Text] [Related]

  • 15. [Plasmapheresis in the combined therapy of Lyell's syndrome].
    Khapiĭ KhKh, Kulikova LP, Kil'diushevskiĭ AV.
    Anesteziol Reanimatol; 1987 Oct; (2):61-2. PubMed ID: 3605779
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Rate of cutaneous drug hypersensitivity].
    Adam H.
    Allerg Immunol (Leipz); 1972 Oct; 18(2):73-80. PubMed ID: 4266964
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
    Caproni M, Torchia D, Schincaglia E, Volpi W, Frezzolini A, Schena D, Marzano A, Quaglino P, De Simone C, Parodi A, Barletta E, Fabbri P.
    Br J Dermatol; 2006 Feb; 154(2):319-24. PubMed ID: 16433803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.